Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale Chief Scientific Officer sold 10,000 shares at $35.98 ($359,800)
  4. 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $38.63 ($386,270)
  5. 4 Open-market sale President and CEO sold 8,333 shares at an average $37.55 ($312,873)
  6. 4 Open-market sale Chief Scientific Officer sold 10,000 shares at $35.00 ($350,000)
  7. 4 Open-market buy Director bought 10,000 shares at $38.03 ($380,252)
  8. 4 Open-market buy Director bought 6,700 shares at $37.28 ($249,780)
  9. 4 Open-market sale President and CEO sold 8,333 shares at $31.95 ($266,239)
  10. 4 Open-market sale President and CEO sold 8,333 shares at an average $32.16 ($267,969)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market sale Chief Financial Officer sold 40,000 shares at an average $38.06 ($1,522,440)
  14. 4 Open-market sale President and CEO sold 9,134 shares at $45.00 ($411,030)
  15. 4 Open-market sale President and CEO sold 8,333 shares at an average $35.72 ($297,693)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Chief Financial Officer sold 18,000 shares at an average $34.21 ($615,840)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 13 of 18 · 351 filings